Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome.
OBJECTIVE
To evaluate factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome.


METHODS
Historic cohort study.


METHODS
Clinic-based data.


METHODS
The population included 214,219 ART cycles performed during 2004 to 2006 and reported to the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System Online database. The study population was limited to cycles of autologous, fresh embryo transfers to women without any treatment complications (212,041), and those developing moderate (1,523) or severe (655) OHSS.


METHODS
None.


METHODS
Risk factors for developing OHSS, and its effect on achieving a pregnancy and live birth, as adjusted odds ratios.


RESULTS
Compared with white women, the risk of developing OHSS was increased for Black women (any OHSS, 1.88; severe OHSS, 2.93) and decreased for Hispanic women (any OHSS, 0.79). Ovarian hyperstimulation syndrome was associated with ovulation disorders (2.01), tubal factors (1.24), and unexplained factors (1.36). Ovarian hyperstimulation syndrome increased the odds of achieving a pregnancy (1.98 with any OHSS, 2.68 with severe), a live birth (any OHSS, 1.86), and a multiple live birth (1.58 with any OHSS, 1.86 with severe). The presence of any OHSS increased the risk of an adverse pregnancy outcome (stillbirth, low birthweight, or preterm birth) by 26% and low birthweight among singletons by 40%.


CONCLUSIONS
Ovarian hyperstimulation syndrome is associated with a higher likelihood of pregnancy, and multiple gestations, but also greater risks for adverse pregnancy outcomes.
Luke
Barbara
B
Department of Obstetrics, Gynecology, and Reproductive Biology, and Department of Epidemiology, Michigan State University, East Lansing, Michigan. Electronic address: lukeb@msu.edu.
Brown
Morton B
MB
Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan.
Morbeck
Dean E
DE
Departments of Obstetrics and Gynecology, and Laboratory Medicine and Pathology, Mayo Clinic, Minneapolis, Minnesota.
Hudson
Susan B
SB
Departments of Obstetrics and Gynecology, and Laboratory Medicine and Pathology, Mayo Clinic, Minneapolis, Minnesota.
Coddington
Charles C
CC
Departments of Obstetrics and Gynecology, and Laboratory Medicine and Pathology, Mayo Clinic, Minneapolis, Minnesota.
Stern
Judy E
JE
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
D000328:Adult; D015331:Cohort Studies; D005006:Ethnicity / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D050498:Live Birth / Q000453:epidemiology; D016471:Ovarian Hyperstimulation Syndrome / Q000150:complications* / Q000453:epidemiology / Q000208:ethnology / Q000209:etiology*; D011247:Pregnancy; D011256:Pregnancy Outcome / Q000453:epidemiology; D018873:Pregnancy Rate; D027724:Reproductive Techniques, Assisted / Q000009:adverse effects / Q000706:statistics & numerical data; D012307:Risk Factors; D016896:Treatment Outcome